TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/28/24 16:08 | 3/26/24 | SGMT | Sagimet Biosciences Inc. | DE | Health | Drug | Pharmaceutical Preparations | Happel David | CA | DO | P,CEO | P | 64 | 5.27 | 0 | 12 | 2 | 639 | D | ||||||||||||||
12/8/23 16:05 | 12/7/23 | SGMT | Sagimet Biosciences Inc. | DE | Health | Drug | Pharmaceutical Preparations | Happel David | CA | DO | P,CEO | P | 7 | 4.10 | 0 | 2 | 0 | 627 | D | ||||||||||||||
11/20/23 21:59 | 11/16/23 | SGMT | Sagimet Biosciences Inc. | DE | Health | Drug | Pharmaceutical Preparations | Happel David | CA | DO | P,CEO | P | 1 | 2.35 | 0 | 1 | New | 1 | D | ||||||||||||||
10/26/17 19:39 | 10/25/17 | HZNP | Horizon Pharma Plc | DE | Health | Drug | Pharmaceutical Preparations | Happel David | L2 | O | EVP,Comm | M.d | 0 | 0.00 | 0 | 8 | 5 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |